INS and Alzheimer disease: Overall, these findings highlight the critical importance for healthcare systems to effectively manage insulin resistance in midlife as a preventing strategy, supporting the World Health Organization’s goal of enhancing the functional capacity of older adults, especially those at heightened risk of AD.